BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1838 related articles for article (PubMed ID: 23305964)

  • 1. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand.
    Gao E; Liu L; Zhu M; Huang Y; Guan F; Gao X; Zhang M; Wang L; Zhang W; Sun Y
    Inorg Chem; 2011 Jun; 50(11):4732-41. PubMed ID: 21520903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
    Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
    Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
    Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
    J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterometallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity.
    Nieto D; González-Vadillo AM; Bruña S; Pastor CJ; Ríos-Luci C; León LG; Padrón JM; Navarro-Ranninger C; Cuadrado I
    Dalton Trans; 2012 Jan; 41(2):432-41. PubMed ID: 22025199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastereomerically pure platinum(II) complexes as antitumoral agents.: The influence of the mode of binding {(N), (N,O)- or (C,N)}- of (1S,2R)[(η5-C5H5)Fe{(η5-C5H4)CHNCH(Me)CH(OH)C6H5}] and the arrangement of the auxiliary ligands.
    Talancón D; López C; Font-Bardía M; Calvet T; Quirante J; Calvis C; Messeguer R; Cortés R; Cascante M; Baldomà L; Badia J
    J Inorg Biochem; 2013 Jan; 118():1-12. PubMed ID: 23123334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
    Roy S; Westmaas JA; Buda F; Reedijk J
    J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. trans-Dichloridopalladium(II) and platinum(II) complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine: synthesis, structural characterization, DNA binding and in vitro cytotoxicity studies.
    Icsel C; Yilmaz VT; Ari F; Ulukaya E; Harrison WT
    Eur J Med Chem; 2013 Feb; 60():386-94. PubMed ID: 23314052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetonimine and 4-imino-2-methylpentan-2-amino platinum(II) complexes: synthesis and in vitro antitumor activity.
    Ruiz J; Rodríguez V; Cutillas N; López G; Bautista D
    Inorg Chem; 2008 Nov; 47(21):10025-36. PubMed ID: 18844342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
    J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platinum complexes with 5-methyl-5(4-pyridyl)hydantoin and its 3-methyl derivatives: synthesis and cytotoxic activity - quantitative structure-activity relationships.
    Bakalova A; Varbanov H; Buyukliev R; Momekov G; Ivanov D; Doytchinova I
    Arch Pharm (Weinheim); 2011 Apr; 344(4):209-16. PubMed ID: 21469169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
    Kratochwil NA; Zabel M; Range KJ; Bednarski PJ
    J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.
    Starha P; Trávnícek Z; Popa I
    J Inorg Biochem; 2010 Jun; 104(6):639-47. PubMed ID: 20304500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and dynamics of methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside complexes with PtCl(2) and PdCl(2), by (1)H, (2)H, (13)C, (15)N and (195)Pt NMR spectroscopy in DMSO, CD(3)CN and H(2)O.
    Bednarek E; Sitkowski J; Kawecki R; Kozerski L; Bocian W; Pazderski L; Priebe W
    Dalton Trans; 2008 Aug; (31):4129-37. PubMed ID: 18688431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
    Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
    Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutral and ionic platinum compounds containing a cyclometallated chiral primary amine: synthesis, antitumor activity, DNA interaction and topoisomerase I-cathepsin B inhibition.
    Albert J; Bosque R; Crespo M; Granell J; López C; Martín R; González A; Jayaraman A; Quirante J; Calvis C; Badía J; Baldomà L; Font-Bardia M; Cascante M; Messeguer R
    Dalton Trans; 2015 Aug; 44(30):13602-14. PubMed ID: 26140359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
    Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
    Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 92.